Advertisement

Indian

International

Insurers face threat as Amazon to enter motor insurance market:GlobalData

Yasha Kuruvilla, Insurance Analyst at GlobalData, comments: “Since customers are reluctant to purchase insurance from tech companies, partnering with a third-party provider is the better strategy, at least until they become recognized names in insurance. Amazon’s partnership with insurtech Acko rather than an incumbent also highlights the retailer’s desire to work with digital and agile companies. This will put added pressure on incumbents, not only due to the emergence of a new large entrant in the market, but also the need to digitalize if they want to work with tech companies in any other future insurance ventures.”

AstraZeneca suspends leading COVID-19 vaccine trials after a participant’s illness

The vaccine, developed with the University of Oxford, has been described by the World Health Organization as probably the world’s leading candidate and the most advanced in terms of development. The suspension dims prospects for an early rollout amid reports that the United States was aiming for a fast-track approval before the November presidential election.

“SCOR well positioned to capture profitable growth opportunities”:Kessler

Kessler commented: “With the Covid-19 pandemic, SCOR has once again demonstrated its capacity to absorb major shocks combined with the resilience of its business model. Regarding the assessment of our exposure to the Covid-19 pandemic that we provided at the end of July 2020, on the P&C side, claims are developing as expected. On the life side, at this stage, claims experience is emerging better than expected. In addition, the pandemic has also exacerbated society’s growing aversion to risk, creating the conditions to drive stronger growth for the reinsurance industry.

First batch of Russia’s Covid-19 vaccine Sputnik V released into public

“The first batch of the ‘Gam-COVID-Vac’ (Sputnik V) vaccine for the prevention of the new coronavirus infection, developed by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia, has passed the necessary quality tests in the laboratories of Roszdravnadzor (medical device regulator) and has been released into civil circulation,” the ministry said in a statement.

Briefs

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Articles

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Features

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Data

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Interviews

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Facts

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.